Amyloid Imaging: Effects of Genes and Advanced Age
William Klunk, MD, PhD is a pioneer in the field of in vivo amyloid imaging in humans. His work spans from basic synthetic chemistry and neuropharmacological evaluation of amyloid imaging tracers to human positron emission tomography (PET) studies of these tracers. His group’s paper on imaging the pathology of Alzheimer’s disease, published in January 2004, is the most frequently cited research paper on this disease. Dr. Klunk also was a member of the Pitt team that invented the groundbreaking Pittsburgh Compound B (PiB).